三重激动剂 comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Updated 2026-03-15. Numbers and descriptions here follow the published literature rather than marketing material.
Body composition is assessed with dual-energy X-ray absorptiometry or comparable methods, which separate fat mass from lean mass. Reported losses include both compartments, and the ratio between them is a subject of ongoing analysis rather than a settled result. Waist circumference, blood pressure, and lipid panels are collected as supporting measures. Resting energy expenditure and substrate oxidation are measured in smaller mechanistic studies, where glucagon receptor activity is expected to matter. These substudies are typically short and small, so their findings carry wide uncertainty.
Interpretation depends on study phase and duration. Phase 2 programs are powered for weight and safety signals, not for cardiovascular or renal outcomes, which require event-driven designs. Gastrointestinal events such as nausea, diarrhea, vomiting, and constipation are the most frequently reported adverse effects and tend to cluster around dose escalation. Small increases in heart rate have been described. Because follow-up after treatment discontinuation is limited, questions about weight regain and durability are open rather than answered.
Retatrutide is a synthetic peptide developed as a single molecule that activates three distinct hormone receptors: GLP-1, GIP, and glucagon. The compound carries the internal designation LY3437943 and was engineered by modifying the backbone of glucose-dependent insulinotropic polypeptide. Its sequence incorporates non-natural amino acids and a fatty acid side chain that extends circulation time. The triple-agonist design aims to combine appetite suppression, improved insulin response, and increased energy expenditure in one agent. Published reports describe it as an investigational product rather than an approved medicine.
Each receptor contributes a different physiological effect. Activation of the GLP-1 receptor slows gastric emptying and reduces appetite signaling in the brain. GIP receptor activity influences insulin secretion and lipid handling, while glucagon receptor stimulation raises energy use and fat oxidation. Combining these pathways is intended to produce weight loss beyond what single- or dual-receptor agonists achieve. Researchers attribute the observed potency to simultaneous engagement of all three targets, though the exact contribution of each receptor to overall effect remains under investigation.
Clinical development has advanced through phase 2 trials in adults with obesity and type 2 diabetes. Reported phase 2 results described substantial average weight reduction over roughly forty-eight weeks of weekly dosing. A phase 3 program is ongoing to confirm efficacy and assess long-term safety. Because the compound has not received regulatory approval, it is not available as a prescription product. Public discussion of retatrutide often conflates trial findings with marketed status, an important distinction when interpreting coverage of the topic.
| Property | Value | Notes |
|---|---|---|
| Trial design | Randomized, double-blind, placebo-controlled | Frequently includes dose-escalation arms |
| Weight endpoint | Percent change from baseline | Reported at a prespecified week |
| Liver fat endpoint | MRI proton density fat fraction | Non-invasive imaging measure |
| Body composition method | Dual-energy X-ray absorptiometry | Separates fat mass from lean mass |
| Common adverse events | Nausea, diarrhea, vomiting | Reported most often during dose escalation |
Stability depends strongly on physical state. Dry powder is comparatively robust when held at -20 °C or below, desiccated and shielded from light; under those conditions degradation is slow and measured over years. Once dissolved, the peptide becomes far more vulnerable: backbone hydrolysis, oxidation of susceptible residues and aggregation all proceed faster in solution, and the rates climb with temperature and with pH far from neutral. Refrigerated storage at 2–8 °C extends usable life for short periods, and repeated freeze–thaw cycles are best avoided.
Identity and purity are established by instrumental methods rather than by appearance. Reversed-phase high-performance liquid chromatography separates the peptide from related impurities and yields a purity value, usually expressed as the share of total peak area. Mass spectrometry checks that the observed mass agrees with the mass calculated from the published sequence, while peptide mapping or amino acid analysis adds structural evidence. Water content, counter-ion identity and residual solvents are sometimes reported as well. A certificate of analysis should name the method behind each figure, because results are method-dependent.
Laboratory handling follows the conventions used for other synthetic peptides. Lyophilized material is weighed and dissolved in an aqueous diluent, typically sterile water or bacteriostatic water, using gentle swirling rather than vigorous shaking, because foaming stresses the chain. Solutions are prepared under clean conditions and, where sterility matters, passed through a suitable filter. Working portions are kept small so that stock material is not repeatedly warmed and cooled, a practice that limits both aggregation and gradual loss of activity.
与仅靶向单一受体的同类药物相比，瑞他鲁肽增加胰高血糖素受体成分，理论上可提高能量消耗并改变脂肪分布。临床中观察到的体重变化是否主要来自该额外机制，目前尚无定论。胃肠道反应是该类药物常见不良事件，试验中通过剂量递增和监测进行管理。停药后体重反弹、个体差异和长期耐受性仍需更多数据。
瑞他鲁肽是一种在研合成肽，同时作用于胰高血糖素样肽-1、葡萄糖依赖性促胰岛素多肽和胰高血糖素受体。该分子属于多受体激动剂类别，尚未获得任何监管机构的上市批准。当前临床开发主要针对肥胖和2型糖尿病，研究代号为LY3437943。已确立的信息包括受体靶点和部分中期试验结果；最终疗效、长期安全性和适用人群仍属开放问题。
开发进程从早期单次和多次给药研究推进至大规模后期试验。公开报告显示，参与者在体重和相关代谢指标上出现变化，但完整数据需经同行评审并接受独立复核。试验设计通常包括随机、双盲和对照设置，以区分药物效应与行为干预。监管提交和标签范围尚未确定；长期维持效果与心血管结局仍是开放问题。
* The 1947 elections had just a complementary character at the federal level (since the deputies elected in 1945 had mandates until 1950) and elected the State Chambers according to the new Constitution. The PCB elected 46 state deputies and become a major party in the Federal District (at this time, the city of Rio de Janeiro). ** The party didn't launch any candidates to the Senate, choosing to support other parties' candidates, following the party tactics of a "democratic front".
It can also be used in nuclear synthesis of higher mass elements; oganesson (element 118) was synthesized by bombarding californium-249 atoms with calcium-48 ions. Users of californium must take into account radiological concerns and the element's ability to disrupt the formation of red blood cells by bioaccumulating in skeletal tissue.
== External links == Media related to Anti-obesity drugs at Wikimedia Commons Prescription Medications to Treat Overweight & Obesity US National Institute of Diabetes and Digestive and Kidney Diseases
Sources: en.wikipedia.org
== Operation == According to Swedish journalist Bertil Lintner, the restaurants are one of several overseas business ventures of Room 39, a North Korean government organization dedicated to acquiring and laundering foreign currency for the North Korean leadership. North Korean defectors have reported that the restaurants are run by local middlemen, who are required to send money every year to the North Korean government. The North Korean staff, who live on the restaurant premises, are said to be thoroughly screened for political loyalty and to be closely watched by on-site North Korean security agents. In the 2000s, according to Daily NK, several attempted escapes by waitresses in China led to the closure of several restaurants and the repatriation of the staff. In 2016, Chinese authorities announced that 13 restaurant workers had defected from Pyongyang restaurants in China to South Korea.
== External links == Gene Ontology: GO:0003720: telomerase activity Human telomerase reverse transcriptase (TERT) gene on genecards.org The Telomerase Database - A Web-based tool for telomerase research Archived 2021-04-19 at the Wayback Machine Three-dimensional model of telomerase at MUN Elizabeth Blackburn's Seminars: Telomeres and Telomerase Telomerase at the U.S. National Library of Medicine Medical Subject Headings (MeSH) Overview of all the structural information available in the PDB for UniProt: O14746 (Human Telomerase reverse transcriptase) at the PDBe-KB. Overview of all the structural information available in the PDB for UniProt: Q0QHL8 (Tribolium castaneum Telomerase reverse transcriptase) at the PDBe-KB.
=== Thermal modulation === Thermal modulators use broad temperature differentials (by way of hot and cold jets) to trap and release analytes eluting out of the primary column. Commercial devices typically use two-stage modulation either via a quad jet approach (where there are two pairs of jets to trap and release the analytes on two different sections of the column) or a delay loop (where the column loops back between a single pair of jets). Both approaches ensure there are two opportunities to focus the analytes. There are also different versions of thermal modulators based on what is used to cool the cold jet (a stream of dry gas, usually air or nitrogen). Liquid nitrogen cooled loop system provide the lowest temperature for thermal modulation, meaning it is capable of modulating volatiles from C2. However, there is the compromise that liquid nitrogen is expensive and causes additional health and safety concerns. Alternatively, consumable-free thermal modulators are available that use a closed cycle refrigeration unit to cool the cold jet.
The raid failed, and the dissidents and mercenaries were killed or captured. The owner of Silvercorp, an ex-US special operations sergeant, said he met with Trump administration officials about the plan. Absent any vote tallies, Maduro was declared the winner of the 2024 Venezuelan presidential election by the government-controlled National Electoral Council; the result was "widely condemned as fraudulent by international observers and the opposition" who found statistical improbabilities in the results. The opposition showed evidence and vote tallies that its candidate, Edmundo González, had won a majority, matching the results of pre-election opinion polls, who was "widely believed to have won [the] election, and by a landslide", according to The New York Times. The Venezuelan government issued an arrest warrant for González, who left the country and was granted asylum in Spain. In January 2025, the Biden administration recognized González as Venezuela's legitimate president-elect. The Trump administration had sought to prosecute Maduro on narco-terrorism charges since at least 2020. At a 2023 press conference, Trump said, "Venezuela was about to collapse. We would have taken over it... [and] kept all that oil."
Sources: en.wikipedia.org
A responder analysis counts participants who cross a threshold, such as five or ten percent weight loss. It complements average percent change by showing how widely results are distributed. The two measures can diverge when a subset of participants loses a large amount.
Mechanistic measures such as energy expenditure and liver fat change come from small substudies and should be read as preliminary. Long-term clinical outcomes are not yet available. Average weight loss figures are better supported than explanations for how the loss is achieved.
Endpoints reported at different weeks, in different baseline BMI ranges, or under different dose-escalation schedules are not directly comparable. Studies in type 2 diabetes often show smaller weight changes than studies in obesity without diabetes. Reporting the population alongside the number keeps comparisons honest.
Retatrutide is an investigational peptide that activates the GLP-1, GIP, and glucagon receptors at the same time. It is being studied for obesity and type 2 diabetes and has not been approved for clinical use. The internal code LY3437943 refers to the same molecule.